Thalia Field

Group Website


2775 Laurel St
Vancouver, British Columbia V5M 1Z9

Vision Statement


Thalia Field



Associate Professor, Neurologist, Postgraduate Fellowship Program Director, Vancouver Stroke Program





Research Interests

Clinical Trials, cognition, stroke, thrombosis, artificial intelligence, patient-centred outcomes.

Research Summary

Dr. Thalia Field is a stroke neurologist and clinician-researcher with a focus on clinical trials. She is currently leading a national study examining treatment strategies and prognosis of cerebral venous thrombosis. She has a particular interest in process improvement in clinical trials, which includes optimizing strategies for participant recruitment and retention, investigating strategies for efficient use of resources, and selecting outcomes that are of relevance to patients. She is also investigating the role of technology in meeting these challenges, including the use of telemedicine for remote recruitment and assessment of study participants, and the use of artificial intelligence to enhance efficiency in trials by enriching trial populations, automating components of participant assessments, and helping to identify important patient-centred outcomes.

Research Highlights


Education and Affiliations


Harvard University, AB, Earth and Planetary Sciences,

Dalhousie University, MD,

University of British Columbia, MHSc, Clinical Epidemiology,


Djavad Mowafaghian Centre for Brain Health, Investigator

Vancouver Coastal Health Research Institute, Investigator

UBC Data Science Institute, Investigator

Publications and Awards

Recent Publications

Selected out of over 20 publications from –

  1. Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children
    KA Nerenberg, KB Zarnke, AA Leung, K Dasgupta, S Butalia, K McBrien,
    Canadian Journal of Cardiology 34 (5), 506-525
  2. Post stroke pain: identification, assessment, and therapy
    RA Harrison, TS Field
    Cerebrovascular diseases 39 (3-4), 190-201
  3. Weather, Chinook, and stroke occurrence
    TS Field, MD Hill
    STROKE-DALLAS- 33 (7), 1751-1756
  4. Tenecteplase–tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion
    SB Coutts, V Dubuc, J Mandzia, C Kenney, AM Demchuk, EE Smith,Suresh Subramaniam, Mayank Goyal, Shivanand Patil, Bijoy K Menon, Philip A Barber, Dar Dowlatshahi, Thalia Field, Negar Asdaghi, Marie-Christine Camden, Michael D Hill
    Stroke 46 (3), 769-774
  5. Relationship between supra-annual trends in influenza rates and stroke occurrence
    TS Field, H Zhu, M Tarrant, JR Mitchell, MD Hill
    Neuroepidemiology 23 (5), 228-235
  6. Achieved blood pressure and outcomes in the secondary prevention of small subcortical strokes trial
    MC Odden, LA McClure, BP Sawaya, CL White, CA Peralta, TS Field, Robert G Hart, Oscar R Benavente, Pablo E Pergola
    Hypertension 67 (1), 63-69
  7. Detection of occult atrial fibrillation in patients with embolic stroke of uncertain source: a work in progress
    JG Andrade, T Field, P Khairy
    Frontiers in Physiology 6, 100
  8. Prevention of deep vein thrombosis and pulmonary embolism in patients with stroke
    TS Field, MD Hill
    Clinical and Applied Thrombosis/Hemostasis 18 (1), 5-19
  9. Current status of antiplatelet agents to prevent stroke
    TS Field, OR Benavente
    Current neurology and neuroscience reports 11 (1), 6-14
  10. Trends in hospital admission for stroke in Calgary
    TS Field, TL Green, K Roy, J Pedersen, MD Hill
    Canadian journal of neurological sciences 31 (3), 387-393
  11. Off-label use of novel anticoagulants for treatment of cerebral venous thrombosis: a Canadian survey
    TS Field, MC Camden, S Al-Shimemeri, G Lui, AYY Lee
    International Journal of Stroke 12 (9), NP16-NP18
  12. Combination Aspirin and Clopidogrel for Secondary Prevention of Ischemic Stroke
    TS Field, M Nakajima, OR Benavente
    Current Treatment Options in Cardiovascular Medicine, 1-12
  13. Extraesophageal manifestations of gastroesophageal reflux.
    SK Field, TS Field, RL Cowie
    Minerva gastroenterologica e dietologica 47 (3), 137-150
  14. Can blood pressure be lowered safely in older adults with lacunar stroke? The Secondary Prevention of Small Subcortical Strokes study experience
    CL White, JM Szychowski, PE Pergola, TS Field, R Talbert, H Lau, K Peri,
    Journal of the American Geriatrics Society 63 (4), 722-729
  15. Penetrating artery territory pontine infarction
    TS Field, OR Benavente
    Rev Neurol Dis 8 (1-2), 30-38

Awards & Recognition

  • Heart and Stroke National New Investigator Award and Henry Barnett Scholar – (2018-2022)
  • Michael Smith Foundation for Health Research Heath Professional Investigator Award – (2018-2020)
  • Vancouver Coastal Health Research Institute Clinician-Scientist Award – (2018-2021)
  • UBC Faculty of Medicine Distinguished Achievement Award – Early Career – (2018)
  • UBC Department of Medicine Martin M. Hoffman Award for Research Excellence (2018)


Current PI funding:

  • CIHR Project Grant – Fall 2018 Competition (2018-2020)
  • CIHR Project Grant – Spring 2019 Competition (2019-2022)
  • Heart and Stroke Grant-in-Aid and Seed Catalyst Grant (2018-2021)
  • Vancouver Coastal Health Research Institute Innovation and Translation Award (2019-2021)
  • American Academy of Neurology Education Research Grant (2019-2020)

Potential research opportunities for learners through:

  • UBC Science Co-op Program
  • UBC Undergraduate Medicine FLEX program
  • Residents and Fellows
  • UBC Postgraduate Education